Centocor takes the bad news with the good.
Gershon
D
D
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001709:Biotechnology; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004731:Endotoxins / Q000627:therapeutic use*; D006801:Humans; D013678:Technology, Pharmaceutical; D014481:United States
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D002317:Cardiovascular Agents; D004731:Endotoxins; C068069:nebacumab